Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pheochromocytoma × Filgrastim × Clear all

Sponsor

Conditions

Lymphoma 50 Multiple Myeloma 47 Leukemia 39 Leukemia, Myeloid, Acute 38 Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Lymphoma, Non-Hodgkin 34 Myelodysplastic Syndromes 31 Hodgkin Disease 31 Lymphoma, Large B-Cell, Diffuse 26 Lymphoma, Mantle-Cell 25 Leukemia, Lymphocytic, Chronic, B-Cell 23 Lymphoma, Follicular 22 Breast Neoplasms 20 Burkitt Lymphoma 18 Lymphoma, B-Cell, Marginal Zone 16 Lymphoma, Large-Cell, Immunoblastic 14 Congenital Abnormalities 14 Recurrence 12 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11 Sarcoma 10 Neoplasms, Plasma Cell 10 Leukemia, Myelomonocytic, Juvenile 9 Leukemia, Biphenotypic, Acute 9 Leukemia, Myelomonocytic, Chronic 8 Hematologic Neoplasms 8 Blast Crisis 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Neuroblastoma 7 Myeloproliferative Disorders 7 Leukemia, Myeloid, Accelerated Phase 7

Interventions

3-Iodobenzylguanidine 3 tipifarnib 1 pazopanib 1 lutetium Lu 177 dotatate 1 lenvatinib 1 guadecitabine 1 fostamatinib 1 copper dotatate CU-64 1 cabozantinib 1 atezolizumab 1 Temozolomide 1 Surgical Procedures, Operative 1 Phenoxybenzamine 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 Iodine-131 1 Doxazosin 1 Capecitabine 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡